Insulet Stock

Insulet Net Income

The Net Income of Insulet (PODD) as of Aug 23, 2026 is 247.10 M USD. In the previous year, Net Income was 418.30 M USD — a change of -40.93% (lower).

Net Income

247.10 MUSD

YoY

-40.93%

Last updated:

In 2026, Insulet's profit amounted to 247.10 M USD, a -40.93% increase from the 418.30 M USD profit recorded in the previous year.

The Insulet Net Income history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Income
Date
Net Income
Jan 1, 2023
206.30 M USD
Jan 1, 2024
418.30 M USD
Jan 1, 2025
247.10 M USD
Jan 1, 2026 (e)
467.45 M USD
Jan 1, 2027 (e)
554.62 M USD
Jan 1, 2028 (e)
667.44 M USD
Jan 1, 2029 (e)
801.03 M USD
Jan 1, 2030 (e)
908.64 M USD
The Insulet Net Income history
YEARNet IncomeYoY
est908.64 MUSD+13.43%
est801.03 MUSD+20.02%
est667.44 MUSD+20.34%
est554.62 MUSD+18.65%
est467.45 MUSD+89.17%
247.10 MUSD-40.93%
418.30 MUSD+102.76%
206.30 MUSD+4,384.78%
4.60 MUSD-72.62%
16.80 MUSD+147.06%
6.80 MUSD-41.38%
11.60 MUSD+252.37%
3.29 MUSD-112.27%
-26.83 MUSD-7.09%
-28.88 MUSD-60.72%
-73.52 MUSD+42.76%
-51.50 MUSD+14.51%
-44.97 MUSD-13.29%
-51.87 MUSD-9.28%
-57.17 MUSD-6.52%
-61.16 MUSD-23.11%
-79.54 MUSD-14.28%
-92.79 MUSD+73.31%
-53.54 MUSD+48.93%
-35.95 MUSD
Access this data via the Eulerpool API

Insulet Revenue

Insulet Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
1.70 B USD
220.00 M USD
206.30 M USD
Jan 1, 2024
2.07 B USD
308.90 M USD
418.30 M USD
Jan 1, 2025
2.71 B USD
473.80 M USD
247.10 M USD
Jan 1, 2026 (e)
3.29 B USD
380.66 M USD
467.45 M USD
Jan 1, 2027 (e)
3.76 B USD
435.08 M USD
554.62 M USD
Jan 1, 2028 (e)
4.29 B USD
495.62 M USD
667.44 M USD
Jan 1, 2029 (e)
4.94 B USD
570.50 M USD
801.03 M USD
Jan 1, 2030 (e)
5.28 B USD
610.76 M USD
908.64 M USD

Insulet Margins

Insulet stock margins

The Insulet margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Insulet. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Insulet.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
68.35 %
12.96 %
12.16 %
Jan 1, 2024
69.79 %
14.91 %
20.19 %
Jan 1, 2025
71.63 %
17.50 %
9.12 %
Jan 1, 2026 (e)
71.63 %
11.56 %
14.20 %
Jan 1, 2027 (e)
71.63 %
11.56 %
14.74 %
Jan 1, 2028 (e)
71.63 %
11.56 %
15.57 %
Jan 1, 2029 (e)
71.63 %
11.56 %
16.23 %
Jan 1, 2030 (e)
71.63 %
11.56 %
17.20 %

Insulet Stock analysis

What does Insulet do? Insulet Corp is an American company that was founded in 2000 and is headquartered in Acton, Massachusetts. Its goal is to improve the quality of life for people with diabetes by developing innovative products that make living with this chronic disease easier. Insulet Corp is known for its product "OmniPod." The OmniPod is a wireless, portable disposable insulin pump system that offers an alternative option to traditional pumping and insulin delivery systems. The OmniPod system consists of two small devices: a pod worn on the skin and a PDM (Personal Diabetes Manager) that regulates insulin delivery. The pod contains an insulin reservoir that communicates wirelessly with the PDM. The insulin dose is administered directly into the body without needles or tubes. Insulet Corp is also introducing the "OmniPod DASH System." This new system combines the proven design of the OmniPod pod with a new color touchscreen handheld device that allows for even easier operation. The DASH system also offers the ability to control insulin dosing from a smartphone, which can be taken with diabetics wherever they go. The success of the OmniPod system has made Insulet Corp a leading company in the diabetes industry. The company has also developed and introduced products and services in other areas of diabetes treatment. Insulet Corp has developed another product called "Amigo." This product is a personalized travel and training program for people who require insulin. Amigo offers specialized and personalized training to support diabetics in managing complex situations. It also offers diet and exercise plans to make living with diabetes easier. Insulet Corp has also developed a software called "OmniPod Horizon." This software is a closed-loop system that automatically adjusts insulin dosing to keep blood sugar levels within the target range. The system is currently in the development phase and is expected to be released in 2020. Insulet Corp has also developed a program called the "OmniPod Partner Program," which targets doctors and pharmacists. The program provides training and educational materials for healthcare providers to help them better treat and manage their patients. Since 2009, Insulet Corp has been listed on the NASDAQ stock exchange and has continuously evolved since then. The company currently has over 1500 employees and operates in North America, Europe, and the Middle East. Insulet Corp is a company focused on the development of innovative, life-changing products and services. It is expected to continue to play a significant role in improving the quality of life for people with diabetes in the future. Insulet is one of the most popular companies on Eulerpool.

Net Income Details

Understanding Insulet's Profit Margins

The profit margins of Insulet represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Insulet's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Insulet's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Insulet's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Insulet’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Insulet stock

Net Income of Insulet is 247.10 M USD in 2026.

Net Income of Insulet changed from 418.30 M USD to 247.10 M USD, representing a -40.93% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Income Insulet since 2006 – with annual values, charts, and detailed analysis.

The achievement of a profit is the biggest goal of a company. The profit can be used for distribution or reinvestment. The profit (also called annual surplus or EAT, earnings after taxes) is the positive difference between income and expenses in a period as shown in the income statement. A negative annual surplus is called annual loss. Both performance measures are also combined under the neutral term annual result.

The Net Income is derived from all revenues / sales minus the expenses in the period under review. The following overview clearly shows which positions contribute to the annual surplus and where the differences lie compared to other variants of profit such as EBT, EBIT, and EBITDA.

Net Income's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Income's Insulet historically and in real time.

The profit in evaluating a stock

History, usage, calculation, and application of earnings in securities trading.

The history of earnings dates back to the beginnings of modern business organization. Since the beginning of industrialization, companies have been established to generate profits, and profits have been considered an essential part of corporate management. In recent years, the importance of earnings for investors has continued to rise, as many investors seek to find stocks that generate solid earnings.

Use of Profits

In securities trading, profits are used to determine the value of a stock. A company that generates profits is considered financially healthy and its stocks are valued higher, while a company that does not generate profits is considered less reliable and therefore receives a lower valuation. Investors can review the profits of each company by examining the relevant documents such as the income statement, the annual financial statements, and the income tax audits.

Calculation of profits

There are several different ways to calculate profits. The simplest way to calculate profits is by calculating net earnings. Net earnings are calculated by subtracting the company's expenses from its revenue. Another way to calculate profits is by calculating operating income. Operating income is calculated by subtracting the company's materials costs and employee wages and salaries from its revenue.

Use of profits

There are many different ways in which investors can use profits when evaluating stocks. One example is calculating the price-to-earnings ratio (P/E ratio). The P/E ratio is the relationship between the price of a stock and the company's earnings. When calculating the P/E ratio, the stock price is divided by the company's earnings. A low P/E value indicates that the stock has a good price-performance ratio, and a high P/E value indicates that the stock has a poor price-performance ratio.

Advantages and disadvantages of using profits

There are many advantages to using earnings in securities trading. Firstly, investors can check the financial health of a company by analyzing earnings. Secondly, investors can make a better decision about the valuation of a stock by calculating the P/E ratio. Thirdly, investors can reduce their risk by choosing stocks with a low P/E ratio.

However, there are also some drawbacks to relying on profits. Firstly, profits can be distorted if a company increases its profits through cost-cutting measures. Secondly, profits can present an inaccurate picture of a company's financial health if they are not calculated correctly. Thirdly, profits may not always be a reliable indicator of a company's future, as they can easily fluctuate.

t('components_kpi_Explanation_34')

Overall, it can be said that profits in securities trading are an important indicator of a company's financial health. Investors can analyze profits to get a better understanding of the company's financial health and make informed decisions about stock valuation. However, there are some disadvantages to using profits as they can sometimes be distorted or inaccurate. Therefore, it is important for investors to be cautious and carefully analyze profits before making a decision to buy or sell stocks.

Access this data via the Eulerpool API

Income Statement — Insulet

All Key Metrics — Insulet